MedPath

Evaluation of the effectiveness of curcumin in the prevention of contrast induced nephropathy in following coronary Angiography

Phase 3
Conditions
Contrast induced nephropathy in following coronary angiography.
Nephrotic syndrome
Registration Number
IRCT20190911044744N4
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Age 18 years and older
Hospitalized in Afshar Yazd Hospital, who is undergoing coronary angioplasty as a non-emergency.
not receiving nephrotoxic drugs.
not taking curcumin containing drugs in the past one month and no history of allergic reaction after taking oral curcumin
Hospitalization in the cardiac intensive care unit for 2 days Informed consent of the patient himself or his legal guar
Informed consent of the patient himself or his legal guardian.

Exclusion Criteria

Pregnant or lactating women
Allergy to curcumin
Receiving nephrotoxic drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath